Insiders PDS Biotechnology Corporation

Equities

PDSB

US70465T1079

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
2.98 ^USD	+1.02%		-3.25%	-40.04%

May. 15	PDS Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 10	NetScientific says PDS Biotech's Versamune meets endpoints	AN

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

PDS Biotechnology Corporation Appoints Stephan Toutain as Chief Operating Officer	May. 02	CI
PDS Biotechnology Names Kirk Shepard as Chief Medical Officer	Jan. 22	MT
PDS Biotechnology Corporation Announces Executive Changes	Jan. 22	CI
Apyx Medical Names Matthew Hill as CFO	Nov. 28	MT
PDS Biotechnology Appoints Lars Boesgaard as Finance Chief	Nov. 28	MT
PDS Biotechnology Corporation Announces Resignation of Matthew Hill as Principal Financial Officer and Principal Accounting Officer, Effective December 1, 2023	Nov. 28	CI
Ambrx Biopharma Names Stephen Glover Board Chairman	23-05-19	MT
TRADING UPDATES: Rogue Baron names chair; Mobile Streams wins contract	22-11-14	AN
NRx Pharmaceuticals Appoints Seth Van Voorhees Finance Chief	22-06-08	MT
PDS Biotechnology Corporation Appoints Spencer Brown as Senior Vice President, General Counsel	22-06-03	CI
PDS Biotechnology Corporation Appoints Sanjay Zaveri as Senior Vice President, Business Development	22-05-18	CI
PDS Biotechnology : Appoints Matthew Hill as Finance Chief	21-10-06	MT
PDS Biotechnology Corporation Announces Executive Changes	21-10-06	CI
Insider Trends: Insider at PDS Biotechnology Exercises Options, Buys Shares, Stretches 90-Buy Trend	21-06-21	MT
Insider Trends: Insider Purchase Adds to PDS Biotechnology Positive Trend	21-06-17	MT
PDS Biotechnology Appoints Immuno-Oncology Experts Dr. Olivera Finn and Dr. Mark Frohlich to Scientific Advisory Board	21-05-18	CI
De Lyle Bloomquist to Retire from the Board of PDS Biotechnology Corporation	21-01-28	CI
PDS Biotechnology Corporation Appoints Seth L. Van Voorhees as Principal Financial Officer and Principal Accounting Officer	20-12-09	CI
Pds Biotechnology Corporation Appoints Seth Van Voorhees as Chief Financial Officer, Effective January 1, 2021	20-12-09	CI
PDS Biotechnology Corporation Appoints Otis W. Brawley as a Class C Director and New Member of the Board	20-11-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders PDS Biotechnology Corporation

Equities

PDSB

US70465T1079

Insiders

Filters